Related references
Note: Only part of the references are listed.Deficiency in Neuronal TGF-β Signaling Leads to Nigrostriatal Degeneration and Activation of TGF-β Signaling Protects against MPTP Neurotoxicity in Mice
Ina Tesseur et al.
JOURNAL OF NEUROSCIENCE (2017)
Seesaw of matrix metalloproteinases (MMPs)
Charu Kapoor et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
ENHANCED IMMUNE RESPONSE TO MMP3 STIMULATION IN MICROGLIA EXPRESSING MUTANT HUNTINGTIN
C. Connolly et al.
NEUROSCIENCE (2016)
Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke
Shihoko Kimura-Ohba et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Human iPSC-Derived Immature Astroglia Promote Oligodendrogenesis by Increasing TIMP-1 Secretion
Peng Jiang et al.
CELL REPORTS (2016)
Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia
Erica M. Weekman et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9
Mar Hernandez-Guillamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases
Marjana Brkic et al.
MEDIATORS OF INFLAMMATION (2015)
TIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain Injury
Stuart L. Gibb et al.
STEM CELLS (2015)
Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells
Karen L. Ring et al.
STEM CELL REPORTS (2015)
The anti-inflammatory role of tissue inhibitor of metalloproteinase-2 in lipopolysaccharide-stimulated microglia
Eun-Jung Lee et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
Artem Kaplan et al.
NEURON (2014)
Association Studies of MMP-9 in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Xianghua He et al.
PLOS ONE (2013)
Aging, exercise, and extracellular matrix in the heart
Hyo-Bum Kwak
JOURNAL OF EXERCISE REHABILITATION (2013)
An Alternate Perspective on the Roles of TIMPs and MMPs in Pathology
Craig S. Moore et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells
Luciana R. Gomes et al.
BMC CANCER (2012)
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
Mahru C. An et al.
CELL STEM CELL (2012)
Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2 BINDING STUDIES AND CRYSTAL STRUCTURE
Jyotica Batra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
INTRANUCLEAR MATRIX METALLOPROTEINASES PROMOTE DNA DAMAGE AND APOPTOSIS INDUCED BY OXYGEN-GLUCOSE DEPRIVATION IN NEURONS
J. W. Hill et al.
NEUROSCIENCE (2012)
Nuclear localization of Matrix metalloproteinases
Ferdinando Mannello et al.
PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY (2012)
Tissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementia
Ashutosh et al.
CELL DEATH & DISEASE (2012)
Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease
Nastasia K-H Lim et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Early defect of transforming growth factor β1 formation in Huntington's disease
Giuseppe Battaglia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Role of matrix metalloproteinase-3 in neurodegeneration
Eun-Mee Kim et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS Myelination
Craig S. Moore et al.
JOURNAL OF NEUROSCIENCE (2011)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease
Daniel P. Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS
Lubin Fang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
John P. Miller et al.
NEURON (2010)
The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells
So-Young Kim et al.
NEUROSCIENCE LETTERS (2010)
TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia
Espen J. Walker et al.
EXPERIMENTAL NEUROLOGY (2009)
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Neuroprotective Effects of Overexpressing Tissue Inhibitor of Metalloproteinase TIMP-1
Emiri Tejima et al.
JOURNAL OF NEUROTRAUMA (2009)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease
Chuan-En Wang et al.
HUMAN MOLECULAR GENETICS (2008)
Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia
Motoaki Fujimoto et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
D. H. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
William G. Stetler-Stevenson
SCIENCE SIGNALING (2008)
Control of matrix metalloproteinase catalytic activity
Hyun-Jeong Ra et al.
MATRIX BIOLOGY (2007)
Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and-2 in ischemic brain injury
S. Magnoni et al.
GENE THERAPY (2007)
Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis
Karim Si-Tayeb et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Matrix metalloproteinases (MMPs) in health and disease: an overview
CJ Malemud
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice display motor deficits
DM Jaworski et al.
JOURNAL OF NEUROBIOLOGY (2006)
Matrix metalloproteinase-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia
YS Kim et al.
JOURNAL OF NEUROSCIENCE (2005)
Multiple roles of matrix metalloproteinases during apoptosis
F Mannello et al.
APOPTOSIS (2005)
Crystal structure of the catalytic domain of human matrix metalloproteinase 10
I Bertini et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The TIMPs tango with MMPs and more in the central nervous system
SJ Crocker et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
MT1-MMP: an enzyme with multidimensional regulation
Y Itoh et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease
JC Adair et al.
STROKE (2004)
Inhibition of calpain cleavage of huntingtin reduces toxicity - Accumulation of calpain/caspase fragments in the nucleus
J Gafni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tissue inhibitor of metalloproteinase (TIMP)-1: The TIMPed balance of matrix metalloproteinases in the central nervous system
J Gardner et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Transforming growth factor β1 overexpression in the nigrostriatal system increases the dopaminergic deficit of MPTP mice
A Sánchez-Capelo et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease
S Lorenzl et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-β1
MC Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
S Lorenzl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons
HK Tan et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease
S Lorenzl et al.
EXPERIMENTAL NEUROLOGY (2002)
Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications
F Mannello et al.
APOPTOSIS (2001)
Tissue-specific proteolysis of huntingtin (htt) in human brain: Evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum
LM Mende-Mueller et al.
JOURNAL OF NEUROSCIENCE (2001)
Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
CL Wellington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
